Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: a Gynecologic Oncology Group study.
about
A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852).Systematic Review and Network Meta-Analysis of Bevacizumab Plus First-Line Topotecan-Paclitaxel or Cisplatin-Paclitaxel Versus Non-Bevacizumab-Containing Therapies in Persistent, Recurrent, or Metastatic Cervical Cancer.New molecular targets against cervical cancer.Evaluation of the psychometric properties of the Functional Assessment of Cancer Therapy-Cervix questionnaire in Brazil.Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240).A pilot study of nimotuzumab plus single agent chemotherapy as second- or third-line treatment or more in patients with recurrent, persistent or metastatic cervical cancer.Pharmacokinetic evaluation of gemcitabine hydrochloride for the treatment of cervical cancer.Emerging drugs for cervical cancer.New pharmacotherapy options for cervical cancer.Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review.Emerging drugs for the treatment of cervical cancer.The safety of drug treatments for cervical cancer.
P2860
Q30275176-CF5FA86A-799F-4F20-92D6-BF519C42E454Q30491531-A40D602A-8E44-42FA-9A96-314355B7AD71Q34700859-F04AA21C-7F1C-4BC6-A57B-E29218DA39F6Q35023494-74F99453-0FE8-431F-B79F-A9695A491769Q35776186-30DA016F-8F91-4845-949B-959E9042BF96Q36214463-4ADD1735-5E2D-487A-984A-DBC51E9474F4Q37939985-4204A8AE-01C8-4723-8271-0665319C0AB9Q38005222-0163D711-8ED5-42DB-9B3F-594A485EDD49Q38160897-7BCEB93B-4477-4418-8DCF-FD18D1A3B249Q38208769-F6E39144-96EB-4168-BA26-7B496A761CDAQ38314157-0A144B84-1921-467F-9F94-F14BC5CDA0D5Q38663857-1CA4F6D9-CB10-42AB-A242-6212500E8C6A
P2860
Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: a Gynecologic Oncology Group study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Health-related quality of life ...... ecologic Oncology Group study.
@ast
Health-related quality of life ...... ecologic Oncology Group study.
@en
type
label
Health-related quality of life ...... ecologic Oncology Group study.
@ast
Health-related quality of life ...... ecologic Oncology Group study.
@en
prefLabel
Health-related quality of life ...... ecologic Oncology Group study.
@ast
Health-related quality of life ...... ecologic Oncology Group study.
@en
P2093
P2860
P1433
P1476
Health-related quality of life ...... necologic Oncology Group study
@en
P2093
Bradley J Monk
Cecelia H Boardman
D Scott McMeekin
David Cella
Helen Q Huang
Lari Wenzel
Lois Ramondetta
P2860
P304
P356
10.1016/J.YGYNO.2010.08.020
P407
P577
2010-09-15T00:00:00Z